Medication info

Jardipin Tablets 10mg (Lercanidipine Hydrochloride)

Prescription medicationTabletOralExpired
Ingredient · strength
Lercanidipine Hydrochloride›10mg
Manufacturer / importer
Youngpoong Pharmaceutical Co., Ltd.
Appearance
Yellow round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 200502470 · Notified 2005.07.18

This product's status changed to Expired on 2024.06.16. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of mild to moderate essential hypertension
Who takes it
Adults
Adult dose
○ Adults Administer 5 ~ 10 mg of lercanidipine hydrochloride orally once daily, at least 15 minutes before a meal. The dose may be increased to 20 mg according to the patient's symptoms. Adjust the dose gradually, as it takes 2 weeks for the maximum antihypertensive effect to become evident. For patients whose blood pressure is not controlled with this medicine, combination therapy with a beta-blocker (e.g., atenolol), diuretic (e.g., hydrochlorothiazide), or ACE inhibitor (e.g., captopril, enalapril) may be used. The dose-response curve is steep and reaches a plateau at doses of 20 ~ 30 mg; therefore, higher doses do not further increase efficacy and may instead increase adverse reactions. ○ Elderly patients: Pharmacokinetic data and clinical experience indicate that adjustment of the daily dose is not necessary; however, caution is required when initiating treatment in elderly patients. ○ Patients with hepatic or renal impairment: Particular caution is required during initiation in patients with mild~moderate hepatic or renal impairment. Although the usual dosage regimen for these patients is consistent, caution is required when increasing the dose to 20 mg per day. In patients with hepatic impairment, the antihypertensive effect may be increased, so dose adjustment should be considered. Do not administer this medicine to patients with severe hepatic or renal impairment.

Ingredients

Manufacturer
Youngpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of mild to moderate essential hypertension

  • Essential hypertension
View approved original text

This medication is used to treat mild to moderate essential hypertension, which refers to a condition where blood pressure is slightly elevated or moderately high.

How to take

Adult dose

○ Adults Administer 5 ~ 10 mg of lercanidipine hydrochloride orally once daily, at least 15 minutes before a meal. The dose may be increased to 20 mg according to the patient's symptoms. Adjust the dose gradually, as it takes 2 weeks for the maximum antihypertensive effect to become evident. For patients whose blood pressure is not controlled with this medicine, combination therapy with a beta-blocker (e.g., atenolol), diuretic (e.g., hydrochlorothiazide), or ACE inhibitor (e.g., captopril, enalapril) may be used. The dose-response curve is steep and reaches a plateau at doses of 20 ~ 30 mg; therefore, higher doses do not further increase efficacy and may instead increase adverse reactions. ○ Elderly patients: Pharmacokinetic data and clinical experience indicate that adjustment of the daily dose is not necessary; however, caution is required when initiating treatment in elderly patients. ○ Patients with hepatic or renal impairment: Particular caution is required during initiation in patients with mild~moderate hepatic or renal impairment. Although the usual dosage regimen for these patients is consistent, caution is required when increasing the dose to 20 mg per day. In patients with hepatic impairment, the antihypertensive effect may be increased, so dose adjustment should be considered. Do not administer this medicine to patients with severe hepatic or renal impairment.

Precautions

This medication should not be used in certain patients. For example, it is contraindicated for those allergic to this medication or similar medications, women who are pregnant or nursing, patients with heart function problems, those with severe liver or kidney disease, patients who have recently experienced a myocardial infarction, and children and adolescents under 18 years old. Patients with a cardiac pacemaker or reduced heart function, mild to moderate liver or kidney impairment, a history of angina, those who consume alcohol, and elderly patients should be monitored closely. Taking this medication may cause side effects such as facial flushing, peripheral edema, palpitations, headache, dizziness, dyspepsia, nausea, and liver function abnormalities. If these symptoms are severe or persistent, it is essential to consult healthcare professionals immediately. Abruptly discontinuing this medication can worsen symptoms, so it should be tapered off gradually under a physician's guidance. Additionally, dizziness or drowsiness may occur, necessitating caution while driving or operating machinery. This medication is metabolized in the liver, and interactions can occur when taken with certain drugs. Specifically, certain antifungals, antibiotics, anticonvulsants, and grapefruit juice can affect its efficacy, so it is advised not to take them together. Women who are pregnant or may become pregnant, as well as those who are nursing, should not take this medication and must use appropriate contraceptive methods. Due to insufficient clinical trial data, this medication should not be used in children and adolescents. For the elderly, no special dosage adjustments are necessary, although caution is advised during initial administration. In the event of an overdose of this medication, severe hypotension or cardiac dysrhythmias may occur, and immediate medical attention should be sought. This medication should be stored out of reach of children, and it is advisable not to transfer it to another container to maintain safety and quality.

Side effects

Flushing, peripheral edema, palpitations, tachycardia, hypotension, chest pain, angina, headache, dizziness, weakness, fatigue, drowsiness, neurasthenia, dyspepsia, nausea, vomiting, abdominal pain, diarrhea, increased serum levels of hepatic aminotransferases, polyuria, nocturia, gingival hyperplasia, rash, myalgia, tremors, insomnia, dry mouth, paresthesia, cough, abdominal distension, erectile dysfunction, arrhythmia, cold sweats, skin tingling, premature contractions, tongue rigidity, increased ventricular premature beats, dyspnea, gastrointestinal disturbances

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1°C and 30°C (room temperature).

Appearance and packaging

Appearance

Yellow round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.